IN2014DN09993A - - Google Patents
Info
- Publication number
- IN2014DN09993A IN2014DN09993A IN9993DEN2014A IN2014DN09993A IN 2014DN09993 A IN2014DN09993 A IN 2014DN09993A IN 9993DEN2014 A IN9993DEN2014 A IN 9993DEN2014A IN 2014DN09993 A IN2014DN09993 A IN 2014DN09993A
- Authority
- IN
- India
- Prior art keywords
- apis
- gamma
- useful
- preparation
- sterile
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0035—Gamma radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/081—Gamma radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IT2012/000136 WO2013168186A1 (en) | 2012-05-09 | 2012-05-09 | Production of sterile active pharmaceutical ingredients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09993A true IN2014DN09993A (ar) | 2015-08-14 |
Family
ID=46321406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9993DEN2014 IN2014DN09993A (ar) | 2012-05-09 | 2012-05-09 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10953115B2 (ar) |
| EP (1) | EP2846845B1 (ar) |
| JP (1) | JP6122485B2 (ar) |
| KR (1) | KR101966830B1 (ar) |
| CN (1) | CN104487099B (ar) |
| BR (1) | BR112014027885B1 (ar) |
| CA (1) | CA2872336C (ar) |
| EA (1) | EA028596B1 (ar) |
| ES (1) | ES2624250T3 (ar) |
| HR (1) | HRP20170529T1 (ar) |
| HU (1) | HUE034356T2 (ar) |
| IN (1) | IN2014DN09993A (ar) |
| MX (1) | MX349920B (ar) |
| PL (1) | PL2846845T3 (ar) |
| PT (1) | PT2846845T (ar) |
| WO (1) | WO2013168186A1 (ar) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210145836A1 (en) * | 2012-05-09 | 2021-05-20 | Icrom Spa | Production of sterile active pharmaceutical ingredients |
| MX2018009497A (es) * | 2016-02-05 | 2019-05-06 | Innopharma Inc | Proceso para fabricar una bolsa de infusion estable, lista para su uso para una formulacion sensible a la oxidacion. |
| BE1024110B1 (fr) * | 2016-10-18 | 2017-11-16 | Auxin Surgery Sa | Dispositif, procédé et formulation pour dissection assistée de manière chimique |
| EP3429555B1 (en) * | 2016-03-14 | 2020-04-29 | AuXin Surgery SA | Mesna formulation and its use |
| DE102017107124A1 (de) * | 2017-04-03 | 2018-10-04 | Ferton Holding S.A. | Pulver zur Reinigung eines inneren Körperteils und/oder eines Implantats, Verfahren zur Herstellung eines solchen Pulvers und geeignete Verwendungen |
| IT202100006794A1 (it) | 2021-03-22 | 2022-09-22 | Icrom Srl | Processo per preparare il verde indocianina |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2004553B1 (de) * | 1970-02-02 | 1971-05-19 | Fa B Braun, 3508 Melsungen | Verfahren zur Herstellung von Leit schienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Korper |
| US6071904A (en) | 1996-12-11 | 2000-06-06 | Alcon Laboratories, Inc. | Process for manufacturing ophthalmic suspensions |
| US20030095890A1 (en) * | 2001-09-24 | 2003-05-22 | Shirley Miekka | Methods for sterilizing biological materials containing non-aqueous solvents |
| AU2006247276A1 (en) * | 2005-05-19 | 2006-11-23 | Albiorex, Llc | Terminal sterilization of injectable collagen products |
| NZ572007A (en) * | 2006-05-09 | 2010-12-24 | Astrazeneca Ab | Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation |
| EA016853B1 (ru) * | 2006-08-24 | 2012-08-30 | Юниверсити Оф Теннесси Рисерч Фаундейшн | Замещенные ациланилиды и их применение |
| GB0626021D0 (en) * | 2006-12-29 | 2007-02-07 | Insense Ltd | The stabilisation of proteins |
| WO2009026473A2 (en) * | 2007-08-21 | 2009-02-26 | Hollis-Eden Pharmaceuticals, Inc. | Stabilized therapeutic compositions and formulations |
| EP2394637A1 (en) * | 2010-05-21 | 2011-12-14 | Zaklady Farmaceutyczne Polpharma SA | Process for obtaining sterile brinzolamide suspensions |
-
2012
- 2012-05-09 PT PT127288322T patent/PT2846845T/pt unknown
- 2012-05-09 BR BR112014027885-7A patent/BR112014027885B1/pt active IP Right Grant
- 2012-05-09 KR KR1020147033573A patent/KR101966830B1/ko active IP Right Grant
- 2012-05-09 MX MX2014013238A patent/MX349920B/es active IP Right Grant
- 2012-05-09 WO PCT/IT2012/000136 patent/WO2013168186A1/en active Application Filing
- 2012-05-09 IN IN9993DEN2014 patent/IN2014DN09993A/en unknown
- 2012-05-09 ES ES12728832.2T patent/ES2624250T3/es active Active
- 2012-05-09 HU HUE12728832A patent/HUE034356T2/en unknown
- 2012-05-09 CN CN201280073019.8A patent/CN104487099B/zh active Active
- 2012-05-09 EP EP12728832.2A patent/EP2846845B1/en active Active
- 2012-05-09 CA CA2872336A patent/CA2872336C/en active Active
- 2012-05-09 EA EA201491845A patent/EA028596B1/ru unknown
- 2012-05-09 PL PL12728832T patent/PL2846845T3/pl unknown
- 2012-05-09 JP JP2015510945A patent/JP6122485B2/ja active Active
- 2012-05-09 US US14/398,912 patent/US10953115B2/en active Active
-
2017
- 2017-04-03 HR HRP20170529TT patent/HRP20170529T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL2846845T3 (pl) | 2017-07-31 |
| EP2846845B1 (en) | 2017-03-01 |
| CA2872336C (en) | 2019-08-13 |
| US10953115B2 (en) | 2021-03-23 |
| WO2013168186A1 (en) | 2013-11-14 |
| BR112014027885B1 (pt) | 2022-07-26 |
| BR112014027885A2 (pt) | 2017-06-27 |
| HUE034356T2 (en) | 2018-02-28 |
| PT2846845T (pt) | 2017-06-02 |
| EA028596B1 (ru) | 2017-12-29 |
| KR20150024821A (ko) | 2015-03-09 |
| CN104487099A (zh) | 2015-04-01 |
| JP6122485B2 (ja) | 2017-04-26 |
| MX349920B (es) | 2017-08-21 |
| CA2872336A1 (en) | 2013-11-14 |
| JP2015523327A (ja) | 2015-08-13 |
| CN104487099B (zh) | 2017-06-20 |
| MX2014013238A (es) | 2015-04-08 |
| EP2846845A1 (en) | 2015-03-18 |
| US20150141412A1 (en) | 2015-05-21 |
| KR101966830B1 (ko) | 2019-04-08 |
| HRP20170529T1 (hr) | 2017-06-16 |
| ES2624250T3 (es) | 2017-07-13 |
| EA201491845A1 (ru) | 2015-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| PH12014501738A1 (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
| PH12015502539A1 (en) | Cenicriviroc compositions and methods of making and using the same | |
| NZ709260A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use | |
| PH12015500713B1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
| MX366899B (es) | Nuevos compuestos. | |
| GB201118656D0 (en) | New compounds | |
| MX2015000990A (es) | Analogos del glucagon. | |
| MX2013001402A (es) | Proceso para preparar tubulisinas. | |
| MX349004B (es) | Nuevos compuestos. | |
| PH12016500433A1 (en) | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine | |
| IN2014DN09993A (ar) | ||
| IN2015DN01165A (ar) | ||
| IN2015DN01164A (ar) | ||
| JO3122B1 (ar) | مشتقات إسترا-5،3،1(10)، 16- تترايين-3- كربوكساميد، عمليات لتحضيرها، مستحضرات دوائية تشتمل عليها واستخدامها لتحضير أدوية | |
| TN2015000007A1 (en) | 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments | |
| SG11201605868XA (en) | Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient | |
| MX2015007731A (es) | Formulacion farmaceutica que comprende ciclesonida. | |
| WO2014027979A3 (en) | Tablet formulations comprising tadalafil and dapoxetine | |
| MX352788B (es) | La mirra en forma de dosificación vaginal para su uso en el tratamiento de la atrofia vaginal como síntoma menopáusico. | |
| UA115307C2 (uk) | Застосування лікарського засобу, що містить рекомбінантний лектин омели для лікування раку шкіри | |
| PH12015501179A1 (en) | Fixed dose pharmaceutical composition comprising mometasone and azelastine | |
| WO2013109202A3 (en) | Pharmaceutical compounds comprising cefetamet | |
| IN2014MU01178A (ar) |